Suppr超能文献

氯沙坦通过激活 2 型糖尿病 GK 大鼠肠系膜动脉中的钙激活钾通道使内皮衍生超极化因子介导的舒张正常化。

Losartan normalizes endothelium-derived hyperpolarizing factor-mediated relaxation by activating Ca2+-activated K+ channels in mesenteric artery from type 2 diabetic GK rat.

机构信息

Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University, Tokyo, Japan.

出版信息

J Pharmacol Sci. 2010;112(3):299-309. doi: 10.1254/jphs.09308fp. Epub 2010 Feb 18.

Abstract

Ca(2+)-activated K(+) (K(Ca)) channels are important for endothelium-derived hyperpolarizing factor (EDHF) signaling. Since treatment with angiotensin II receptor blockers (ARBs) improves vasculopathies in type 2 diabetic patients, we asked whether the EDHF-type relaxation and its associated K(Ca) channels [small (SK(Ca))-, intermediate (IK(Ca))-, and large (BK(Ca))-conductance channels] are abnormal in mesenteric arteries isolated from Goto-Kakizaki (GK) rats at the chronic stage of type 2 diabetes (34 - 38 weeks) and whether an ARBs (losartan, 25 mg . kg(-1) . day(-1) for 2 weeks) might correct these abnormalities. Although the acetylcholine chloride-induced EDHF-type relaxation in mesenteric arteries from GK rats was reduced versus the Wistar controls, it was significantly restored by losartan treatment. The SK(Ca)-blocker apamin or the IK(Ca)-blocker 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34) inhibited such relaxations in the losartan-treated or -untreated Wistar groups and in the losartan-treated GK group, but not in the losartan-untreated GK group. The BK(Ca)-blocker iberiotoxin had a significant inhibitory effect in only one of these groups, the losartan-treated GK. The relaxations induced by the SK(Ca)/IK(Ca) activator NS309 and the BK(Ca) activator NS1619, which were impaired in GK rats, were normalized by losartan treatment. We conclude that losartan improves EDHF-type relaxation in GK rats at least partly by normalizing SK(Ca)/IK(Ca) activities and increasing BK(Ca) activity.

摘要

钙激活钾(K(Ca))通道对于内皮衍生超极化因子(EDHF)信号传递非常重要。由于血管紧张素 II 受体阻滞剂(ARB)的治疗可以改善 2 型糖尿病患者的血管病变,因此我们想知道 2 型糖尿病慢性期(34-38 周)分离的肠系膜动脉中 EDHF 型松弛及其相关的 K(Ca)通道(小电导钙激活钾通道(SK(Ca))、中间电导钙激活钾通道(IK(Ca))和大电导钙激活钾通道(BK(Ca)))是否存在异常,以及 ARB(氯沙坦,25mg.kg(-1).day(-1),治疗 2 周)是否可以纠正这些异常。尽管 GK 大鼠肠系膜动脉对氯化乙酰胆碱诱导的 EDHF 型松弛反应降低,但氯沙坦治疗可显著恢复这种松弛反应。SK(Ca)阻断剂 apamin 或 IK(Ca)阻断剂 1-[(2-氯苯基)二苯基甲基]-1H-吡唑(TRAM-34)抑制了氯沙坦治疗或未治疗的 Wistar 组以及氯沙坦治疗的 GK 组中的这种松弛反应,但对氯沙坦未治疗的 GK 组没有抑制作用。仅在氯沙坦治疗的 GK 组中,BK(Ca)阻断剂 iberiotoxin 具有显著的抑制作用。在 GK 大鼠中受损的 SK(Ca)/IK(Ca)激活剂 NS309 和 BK(Ca)激活剂 NS1619 诱导的松弛反应,经氯沙坦治疗后可恢复正常。我们的结论是,氯沙坦至少部分通过使 SK(Ca)/IK(Ca)活性正常化和增加 BK(Ca)活性来改善 GK 大鼠的 EDHF 型松弛反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验